Качественная клиническая практика (Oct 2020)

Current and future use of umifenovir in patients with COVID-19

  • Yu. Yu. Kiselev,
  • K. A. Zagorodnikova,
  • D. V. Ivashchenko,
  • A. V. Krykov,
  • I. N. Sychev,
  • A. S. Matveev,
  • K. B. Mirzaev,
  • V. A. Otdelenov,
  • V. M. Tsvetov,
  • A. V. Dmitriev,
  • V. V. Poroikov,
  • D. A. Sychev

DOI
https://doi.org/10.37489/2588-0519-2020-S4-75-80
Journal volume & issue
Vol. 0, no. 4S
pp. 75 – 80

Abstract

Read online

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental” nature of this treatment.

Keywords